|
Volumn 6, Issue 4, 2000, Pages 379-392
|
Cell cycle molecular targets in novel anticancer drug discovery
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZAZEPINE DERIVATIVE;
CELL CYCLE PROTEIN;
CYCLIN D;
CYCLIN DEPENDENT KINASE;
CYCLIN DEPENDENT KINASE INHIBITOR;
CYCLIN E;
CYCLINE;
FLAVOPIRIDOL;
INDIRUBIN;
OLOMOUCINE;
ROSCOVITINE;
BREAST CANCER;
CANCER THERAPY;
CELL CYCLE G1 PHASE;
COLORECTAL CANCER;
DRUG STRUCTURE;
ENZYME INHIBITION;
HUMAN;
LUNG NON SMALL CELL CANCER;
MOLECULAR DYNAMICS;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
REVIEW;
CANCER CHEMOTHERAPY;
DRUG DESIGN;
EDITORIAL;
GENE ACTIVATION;
GENE FUNCTION;
GENE THERAPY;
MUTATION;
TUMOR SUPPRESSOR GENE;
|
EID: 0034121281
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612003400948 Document Type: Review |
Times cited : (239)
|
References (12)
|